These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8394064)

  • 1. [Trial of combined radiotherapy and low-dose carboplatin for non-small cell lung cancer].
    Kaneko T; Okagawa K; Mizunoya S; Nishiyama K; Ikeda T; Ito M
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1401-3. PubMed ID: 8394064
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction therapy with carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal radiotherapy in the treatment of locally advanced, unresectable non-small cell lung cancer: preliminary report of a phase I trial.
    Socinski MA; Clark JA; Halle J; Steagall A; Kaluzny B; Rosenman JG
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-117-S12-122. PubMed ID: 9331135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Concurrent radiotherapy and chemotherapy for non-small-cell lung cancer--continuous infusion of low dose cisplatin and 5-FU].
    Itoh Y; Fuwa N; Kikuchi Y; Matsumoto A; Muramoto H; Kato E; Shinoda M; Sugiura T
    Gan To Kagaku Ryoho; 1996 Oct; 23(12):1721-4. PubMed ID: 8886053
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of daily low-dose carboplatin in radiotherapy for non-small cell lung cancer.
    Satoh H; Ohara K; Fuji H; Ishikawa H; Yamashita YT; Kamma H; Ohtsuka M; Hasegawa S
    Anticancer Res; 1998; 18(6B):4625-7. PubMed ID: 9891530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The combined therapy of carboplatin, fluorouracil and radiotherapy for moderate and advanced non-small cell lung cancer].
    Qiao T; Xin L; Liu H
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Sep; 22(9):536-7. PubMed ID: 11776765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Concurrent chemoradiotherapy using a single agent for unresectable stage III non-small cell lung cancer].
    Tamura A; Mikami A; Sagara Y; Hebisawa A
    Gan To Kagaku Ryoho; 2000 Oct; 27(11):1755-8. PubMed ID: 11057330
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.
    Langer CJ; Movsas B; Hudes R; Schol J; Keenan E; Kilpatrick D; Yeung C; Curran W
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standard thoracic radiotherapy with or without concurrent daily low-dose carboplatin in elderly patients with locally advanced non-small cell lung cancer: a phase III trial of the Japan Clinical Oncology Group (JCOG9812).
    Atagi S; Kawahara M; Tamura T; Noda K; Watanabe K; Yokoyama A; Sugiura T; Senba H; Ishikura S; Ikeda H; Ishizuka N; Saijo N;
    Jpn J Clin Oncol; 2005 Apr; 35(4):195-201. PubMed ID: 15845568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel plus carboplatin and concurrent radiation therapy for patients with locally advanced non-small cell lung cancer.
    Choy H; Akerley W; Safran H; Graziano S; Chung C
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):117-9. PubMed ID: 9007137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Trial of combined radiotherapy and chemotherapy (CBDCA) for post-operative non-small cell lung cancer (N2)].
    Nakano N; Kishima H; Yamamura N; Ueda S; Kameda Y; Miyagawa M
    Gan To Kagaku Ryoho; 1999 May; 26(6):845-7. PubMed ID: 10410157
    [No Abstract]   [Full Text] [Related]  

  • 11. Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin/paclitaxel in patients with early-stage (I/II) non-small-cell lung cancer: long-term results of a phase II study.
    Jeremić B; Milicić B; Acimović L; Milisavljević S
    J Clin Oncol; 2005 Oct; 23(28):6873-80. PubMed ID: 16192579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Concurrent daily low-dose cisplatin combined with chest irradiation in advanced non-small cell lung cancer].
    Fujii S; Hamamoto Y; Sugai Y
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1397-9. PubMed ID: 8394063
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemoradiotherapy in non-small cell lung cancer: paclitaxel/carboplatin/radiotherapy in regionally advanced disease.
    Belani CP; Aisner J; Bahri S; Jett J; Day R; Capazolli MJ; Hiponia D; Engstrom C
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):113-6. PubMed ID: 9007136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of carboplatin in the treatment of lung cancer].
    Bréchot JM
    Bull Cancer; 2000 Aug; 87 Spec No():34-9. PubMed ID: 11082721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daily paclitaxel and thoracic radiation therapy for non-small cell lung cancer: preliminary results.
    Rathmann J; Leopold KA; Rigas JR
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):130-5. PubMed ID: 10210552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.
    Seiwert TY; Connell PP; Mauer AM; Hoffman PC; George CM; Szeto L; Salgia R; Posther KE; Nguyen B; Haraf DJ; Vokes EE
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):515-22. PubMed ID: 17255273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary analysis of a phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small cell lung cancer.
    Choy H; DeVore RF; Hande KR; Porter LL; Rosenblatt P; Yunus F; Schlabach L; Smith C; Shyr Y; LaPorte K; Johnson DH
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-21-S12-26. PubMed ID: 9331115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weekly paclitaxel and carboplatin with concurrent radiation therapy in locally advanced non-small cell lung cancer: phase I study.
    Endo M; Takada Y; Obayashi K; Kotani Y; Satouchi M; Kado T; Sugimura K
    Radiat Med; 2005 Aug; 23(5):331-5. PubMed ID: 16342905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal thoracic radiation therapy in unresectable stage IIIA/B nonsmall cell lung carcinoma: a modified Phase I trial.
    Socinski MA; Rosenman JG; Schell MJ; Halle J; Russo S; Rivera MP; Clark J; Limentani S; Fraser R; Mitchell W; Detterbeck FC
    Cancer; 2000 Aug; 89(3):534-42. PubMed ID: 10931452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer.
    Schild SE; McGinnis WL; Graham D; Hillman S; Fitch TR; Northfelt D; Garces YI; Shahidi H; Tschetter LK; Schaefer PL; Adjei A; Jett J
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1106-11. PubMed ID: 16730134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.